Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase-Reference-Cited by-同舟云学术

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Published:1995-01 Issue:1-2 Volume:18 Page:87-92
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Suki Samer,Swan Forrest,Tucker Susan,Fritsche Herbert A.,Redman John R.,Rodriguez Maria Alma,McLaughlin Peter,Romaguera Jorge,Hagemeister Fredrick B.,Velasquez William S.,Sarris Andreas H.,Younes Anas,Cabanillas Fernando

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199509064927

Reference40 articles.

1. Prognostic relevance of thymidine kinase isozymes in adult non- Hodgkin's lymphoma

2. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

3. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma

4. Serumβ2-microglobulin in malignant lymphoma

5. Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: A multivariate analysis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always Infection;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2021-04

2. Prognostic Significance of Serum Beta-2 Microglobulin in Patients with Non-Hodgkin Lymphoma;Oncology;2014

3. Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone;Leukemia & Lymphoma;2013-03-14

4. Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer;Biomarkers;2012-11-02

5. Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma;American Journal of Hematology;2012-03-03